Mainz, Germany, January 12, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will provide a strategic business update and outline the Company’s focus areas for 2026, including an ...

In combination with expense growth of 3%, we drove 507 basis points of positive operating leverage on a reported basis and ...

The cautious start to indices follows a fifth straight session of losses on Friday, which pushed the Nifty closer to its ...

Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.

Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE and next-generation, highly selective ...

Good morning, and welcome to the 2025 Fourth Quarter Earnings Conference Call hosted by BNY. [Operator Instructions] Please ...

Coherus Oncology, Inc. ( CHRS) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 1:30 PM EST Good morning everyone. It's still the morning. Thanks for joining us for another session at ...

Detailed price information for Diginex Limited (DGNX-Q) from The Globe and Mail including charting and trades.

Following JPMorgan’s results on Tuesday, earnings from megabank rivals Bank of America Corp, Wells Fargo & Co, Citigroup, ...

Franklin Resources' aggressive focus on Alternative Assets has failed to deliver management fee margin expansion, raising ...

Tesco’s failure to meet lofty City expectations and a warning by the owner of Primark today fuelled retail sector selling ...